Christopher Beck
Directeur des opérations chez CONTEXT THERAPEUTICS INC.
Profil
Christopher Beck is a professional with experience in various pharmaceutical companies.
He is currently working as Senior Vice President-Operations at Context Therapeutics, Inc. Prior to this, he worked as Vice President-Program Management at Galera Therapeutics, Aevi Genomic Medicine, and Formular Pharmaceuticals.
He completed his undergraduate degree at Drexel University and earned an MBA from The Pennsylvania State University.
Postes actifs de Christopher Beck
Sociétés | Poste | Début |
---|---|---|
CONTEXT THERAPEUTICS INC. | Directeur des opérations | 05/01/2022 |
Anciens postes connus de Christopher Beck
Sociétés | Poste | Fin |
---|---|---|
AEVI GENOMIC MEDICINE, INC. | Corporate Officer/Principal | - |
Formular Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
GALERA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Christopher Beck
Drexel University | Undergraduate Degree |
The Pennsylvania State University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
GALERA THERAPEUTICS, INC. | Health Technology |
CONTEXT THERAPEUTICS INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Aevi Genomic Medicine, Inc.
Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
Formular Pharmaceuticals, Inc. |